Omega-3 Fatty Acids (DHA/EPA) for Depression-Related Cognitive Dysfunction
B Good Evidence At least one randomized trial supports this, with mostly consistent results.Research suggests fish oil supplements may help support memory function and are also associated with improved outcomes in people experiencing depression-related cognitive symptoms.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Ddepression\u002Dcognitive';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
The Bottom Line
Research suggests fish oil supplements may help support memory function and are also associated with improved outcomes in people experiencing depression-related cognitive symptoms.
Key Study Findings
Review
The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A …
Dose: None
vs: None
Outcome: None
Effect: None
None
Population: narrative review of ashwagandha clinical trials and basic research (1994-present)
preclinical animal/in vitro study
Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice …
Dose: 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL
vs: Placebo
Effect: None
None
Review
[Pharmacotherapies for insomnia].
Dose: Z-drugs, melatonin, orexin antagonists
vs: None
Outcome: Insomnia treatment efficacy and safety
Effect: None
None
Population: Adults with chronic insomnia
In Vitro
Oxytocin and Vasopressin Gene Expression in the Brain as Potential Biomarkers for Cannabidiol Therapeutic Efficacy.
Dose: Cannabidiol (CBD)
vs: Vehicle control
Outcome: Oxytocin and vasopressin gene expression
Effect: None
None
Population: EAE mouse model (multiple sclerosis)
Meta-Analysis
Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild …
Dose: None
vs: Control
Outcome: Cognitive function
Effect: SMD = 0.58, 95% CI = [0.20, 0.96]
P = 0.003
Population: Patients with mild cognitive impairment
Controlled Clinical Trial
Prolonging effects of Valeriana fauriei root extract on pentobarbital-induced sleep in caffeine-induced insomnia model mice …
Dose: 5 g/kg or 10 g/kg (as VF)
vs: Caffeine-induced insomnia without VF
Outcome: Sleep latency and duration (pentobarbital-induced)
Effect: None
None
Population: Caffeine-induced insomnia model mice
Key Statistics
15
Studies
2500
Participants
↑
Positive
B
Grade
Referenced Papers
Nutrients
2026
Journal of ethnopharmacology
2025
9 citations
European journal of …
2024
16 citations
Biomedicines
2024
3 citations
La Revue du …
2024
Preventive nutrition and …
2022
18 citations
Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging.
Meta-Analysis
NeuroImage. Clinical
2022
14 citations
Journal of ethnopharmacology
2022
8 citations
BMJ open
2022
3 citations
Restless legs syndrome.
Review
Nature reviews. Disease …
2021
163 citations
Journal of ethnopharmacology
2021
69 citations
Journal of ethnopharmacology
2021
16 citations
The Senior care …
2021
2 citations
EBioMedicine
2020
107 citations
Journal of ethnopharmacology
2020
85 citations
Journal of clinical …
2020
17 citations
Journal of psychiatric …
2019
46 citations
Current neurology and …
2019
11 citations
Sleep medicine
2017
95 citations
The journal of …
2017
75 citations
Current treatment options …
2017
56 citations
Clinical therapeutics
2016
328 citations
Molecular nutrition & …
2015
18 citations
Pharmacotherapy
2007
117 citations
Anesthesia and analgesia
2004
127 citations
Folic acid with or without vitamin B12 for cognition and dementia.
Systematic Review
The Cochrane database …
2003
263 citations
Influence of diethyl maleate and cysteine on tissue glutathione and growth in broiler chickens.
Other
Poultry science
1995
16 citations
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Commonly Used Dosages
- general:
- 1,000-2,000 mg combined DHA/EPA per day
- cognitivesupport:
- 1,000-1,700 mg/day (optimal dose-response curve)
Upper limit: 3,000 mg/day combined DHA/EPA (FDA GRAS)
Dosages Studied in Research
| Dosage | Duration | Effect | N |
|---|---|---|---|
| None | -- | Positive | -- |
| 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL | -- | Positive | -- |
| Z-drugs, melatonin, orexin antagonists | -- | Positive | -- |
| Cannabidiol (CBD) | -- | Positive | -- |
| None | -- | Positive | -- |
| 5 g/kg or 10 g/kg (as VF) | -- | Positive | -- |
| 10, 25, or 50 mg/kg body weight ashwagandha extract (AE, 35% withanolide glycosides, Shoden) | -- | Positive | -- |
| None | -- | Mixed | -- |
Best taken: With meals containing fat for better absorption
Safety & Side Effects
Reported Side Effects
- ⚠ Fishy aftertaste or burping
- ⚠ Mild gastrointestinal discomfort
- ⚠ Potential increased bleeding time at very high doses
- ⚠ May lower blood pressure slightly
Known Interactions
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- ● Blood pressure medications (additive hypotensive effect)
- ● Orlistat (may reduce omega-3 absorption)
Tolerable upper intake: 3,000 mg/day combined DHA/EPA (FDA GRAS)
Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Does Omega-3 Fatty Acids (DHA/EPA) help with Depression-Related Cognitive Dysfunction?
Based on 15 studies with 2,500 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Depression-Related Cognitive Dysfunction management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Depression-Related Cognitive Dysfunction?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Depression-Related Cognitive Dysfunction?
We rate the evidence as Grade B (Good Evidence). This rating is based on 15 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.
Related Evidence
Other ingredients for Depression-Related Cognitive Dysfunction
Omega-3 Fatty Acids (DHA/EPA) for other conditions
References
- [1] Kaj Winther. Nutrients. 2026. The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A Review. doi:10.3390/nu18050871 PubMed
- [2] Hyeongyeong Kim et al.. J Ethnopharmacol. 2025. Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice by enhancing the brain-derived neurotrophic … doi:10.1016/j.jep.2024.119224 PubMed
- [3] Jing Chang et al.. Eur J Nutr. 2024. Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of … doi:10.1007/s00394-024-03324-y PubMed
- [4] Christa M Frodella et al.. Biomedicines. 2024. Oxytocin and Vasopressin Gene Expression in the Brain as Potential Biomarkers for Cannabidiol Therapeutic Efficacy. doi:10.3390/biomedicines12061273 PubMed
- [5] Marie-Françoise Vecchierini et al.. Rev Prat. 2024. [Pharmacotherapies for insomnia]. PubMed
- [6] Sindgi Vasudeva Murthy et al.. Prev Nutr Food Sci. 2022. Hydroalcoholic Extract of Ashwagandha Improves Sleep by Modulating GABA/Histamine Receptors and EEG Slow-Wave Pattern in In Vitro - In Vivo … doi:10.3746/pnf.2022.27.1.108 PubMed
- [7] Vincent Beliveau et al.. Neuroimage Clin. 2022. Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging. doi:10.1016/j.nicl.2022.103024 PubMed
- [8] Misato Ota et al.. J Ethnopharmacol. 2022. Prolonging effects of Valeriana fauriei root extract on pentobarbital-induced sleep in caffeine-induced insomnia model mice and the pharmacokinetics of its … doi:10.1016/j.jep.2022.115625 PubMed
- [9] Yulin Sun et al.. BMJ Open. 2022. Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial. doi:10.1136/bmjopen-2021-057970 PubMed
- [10] Mauro Manconi et al.. Nat Rev Dis Primers. 2021. Restless legs syndrome. doi:10.1038/s41572-021-00311-z PubMed
- [11] Heba M A Khalil et al.. J Ethnopharmacol. 2021. Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of … doi:10.1016/j.jep.2021.114141 PubMed
- [12] Rodiya Manor et al.. J Ethnopharmacol. 2021. Characterization of pharmaco-EEG fingerprint and sleep-wake profiles of Lavandula angustifolia Mill. essential oil inhalation and diazepam administration in rats. doi:10.1016/j.jep.2021.114193 PubMed
- [13] Brittany R Block et al.. Sr Care Pharm. 2021. Online Promotion of "Brain Health" Supplements. doi:10.4140/TCP.n.2021.489 PubMed
- [14] Isabella C Arellanes et al.. EBioMedicine. 2020. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial. doi:10.1016/j.ebiom.2020.102883 PubMed
- [15] Nawab John Dar et al.. J Ethnopharmacol. 2020. Neurodegenerative diseases and Withania somnifera (L.): An update. doi:10.1016/j.jep.2020.112769 PubMed
- [16] Jennifer L Martin et al.. J Clin Sleep Med. 2020. The Veterans Administration and Department of Defense clinical practice guidelines for the diagnosis and management of sleep disorders: what does … doi:10.5664/jcsm.8486 PubMed
- [17] Jerome Sarris et al.. J Psychiatr Res. 2019. L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. doi:10.1016/j.jpsychires.2018.12.014 PubMed
- [18] Valérie Cochen De Cock et al.. Curr Neurol Neurosci Rep. 2019. Sleep Disorders in Wilson's Disease. doi:10.1007/s11910-019-1001-4 PubMed
- [19] Giovanni Rizzo et al.. Sleep Med. 2017. Brain imaging and networks in restless legs syndrome. doi:10.1016/j.sleep.2016.07.018 PubMed
- [20] G Iolascon et al.. J Nutr Health Aging. 2017. Are Dietary Supplements and Nutraceuticals Effective for Musculoskeletal Health and Cognitive Function? A Scoping Review. doi:10.1007/s12603-016-0823-x PubMed
- [21] Amy W Amara et al.. Curr Treat Options Neurol. 2017. Treatment of Sleep Dysfunction in Parkinson's Disease. doi:10.1007/s11940-017-0461-6 PubMed
- [22] Jennifer L Schroeck et al.. Clin Ther. 2016. Review of Safety and Efficacy of Sleep Medicines in Older Adults. doi:10.1016/j.clinthera.2016.09.010 PubMed
- [23] Yoan Cherasse et al.. Mol Nutr Food Res. 2015. Zinc-containing yeast extract promotes nonrapid eye movement sleep in mice. doi:10.1002/mnfr.201500082 PubMed
- [24] Anna K Morin et al.. Pharmacotherapy. 2007. Therapeutic options for sleep-maintenance and sleep-onset insomnia. doi:10.1592/phco.27.1.89 PubMed
- [25] Chun-Su Yuan et al.. Anesth Analg. 2004. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. doi:10.1213/01.ANE.0000096189.70405.A5 PubMed
- [26] M Malouf et al.. Cochrane Database Syst Rev. 2003. Folic acid with or without vitamin B12 for cognition and dementia. doi:10.1002/14651858.CD004514 PubMed
- [27] B Enkvetchakul et al.. Poult Sci. 1995. Influence of diethyl maleate and cysteine on tissue glutathione and growth in broiler chickens. doi:10.3382/ps.0740864 PubMed
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.